Clinical trial
Management of Retinitis Pigmentosa Via Repetitive Electromagnetic Stimulation and Autologous Platelet Rich Plasma
NCT04252534 is registered in ClinicalTrials.gov with Ankara Universitesi Teknokent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management of Retinitis Pigmentosa Via Repetitive Electromagnetic Stimulation and Autologous Platelet Rich Plasma
- Lead sponsor
- Ankara Universitesi Teknokent
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- December 30, 2019
- Enrollment
- 60 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.